US Patent 11618789 Clinical assessment of M-protein response in multiple myeloma
Patent 11618789 was granted and assigned to MorphoSys on April, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 3, 2017
0
Date of Patent
April 4, 2023
0
Patent Applicant
Patent Application Number
16080870
0
Patent Inventor Names
Stefan Härtle
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11618789 Clinical assessment of M-protein response in multiple myeloma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.